Clinical Trial Update: Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 safety and reactogenicity study comparing a single dose of monovalent high-dose IPV type 2 vaccine (m-IPV2 HD) to standard trivalent IPV in healthy adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Inactivated Poliovirus Vaccine (IPV) (Inactivated Poliovirus Vaccine)
• monovalent high-dose inactivated poliovirus type 2 vaccine (m-IPV2 HD) (monovalent high-dose inactivated poliovirus type 2 vaccine)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Poliomyelitis | Phase 1 | Status: COMPLETED